Transaction · 0001638643-26-000031

O'Day Daniel Patrick

O'Day Daniel Patrick, CHAIR, CEO, reported an open-market or private sale at GILEAD SCIENCES, INC. involving 1600.000000 shares for an estimated $236013.92. Reported holdings after the transaction were 590533.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SCHAIR, CEO
GILDGILEAD SCIENCES, INC.
Filing timeSep 02
Trade dateSep 01, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$149.61
Pre-filing
1mo ago -13.0%1w ago -1.1%1d ago -2.2%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

GILD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
GILD since 2026-09-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001638643-26-000031
Common Stock
Transaction date
Sep 01, 2026
Filed Sep 02, 2026, 08:12 PM · 1d delay
Shares
1.60k sh
$14.7k per share
Estimated value
-$23.6M
Computed from shares × price
Holdings after
590k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chairman & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.

  2. F2

    Sale prices for the transactions reported range from $146.94 to $147.92. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issu…

  3. F3

    Sale prices for the transactions reported range from $147.95 to $148.93. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issue…

  4. F4

    Sale prices for the transactions reported range from $148.96 to $149.94. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issu…

Original filing · 0001638643-26-000031
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

GILD